Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 11:38 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 721–744 of 1,131 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Functional MRI Clear all

Conditions: Complex Regional Pain Syndromes
Interventions: observation and measure of trajectory of recovery in CRPS; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 10 Years to 17 Years
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Schizophrenia, Normal Physiology
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 3,273 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2000
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV Associated Neurocognitive Disorder
Interventions: Fluconazole, Paroxetine, Paroxetine and Fluconazole, Placebo; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Epilepsy
Interventions: Not listed
Lead sponsor: Swedish Medical Center; Other
Eligibility: 10 Years to 65 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pituitary Adenoma
Interventions: FET-PET/MRI; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Movement Disorder, Tourette Syndrome, Healthy Volunteer
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2019
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Healthy Adults
Interventions: Not listed
Lead sponsor: Lumos Labs, Inc.; Industry
Eligibility: 25 Years to 40 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Cocaine Use Disorder, Cocaine Dependence
Interventions: Transcranial magnetic stimulation (TMS); Device
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 22 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aging, Mild Cognitive Impairment
Interventions: Conversational Engagement; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 75 Years and older
Enrollment: 186 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: Boston, Massachusetts • Ann Arbor, Michigan

Conditions: Aging
Interventions: Nicotine gum, Placebo gum; Drug · Other
Lead sponsor: University of California, Berkeley; Other
Eligibility: 18 Years to 85 Years
Enrollment: 44 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Berkeley, California

Conditions: Alcoholism, fMRI, Rewarding Mediating System
Interventions: Not listed
Lead sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA); NIH
Eligibility: 21 Years to 60 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Mild Cognitive Impairment
Interventions: sham tDCS, active tDCS; Device
Lead sponsor: University of Michigan; Other
Eligibility: 60 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Phobia, Social
Interventions: Cannabidiol, Placebo; Drug
Lead sponsor: Massachusetts Institute of Technology; Other
Eligibility: 18 Years to 55 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Major Depressive Disorder
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 60 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Mild Cognitive Impairment, MCI, Aging, Alzheimer's Disease, AD
Interventions: Methylene Blue, FD&C Blue # 2, Phenazopyridine hydrochloride; Drug
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 45 Years to 89 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Anesthesia, Pain, Remimazolam
Interventions: Remimazolam, Peripheral Nerve Stimulation; Drug · Device
Lead sponsor: Keith M Vogt; Other
Eligibility: 18 Years to 59 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Alcohol Abuse
Interventions: Alcohol, Saline; Drug
Lead sponsor: Mark Fillmore; Other
Eligibility: 21 Years to 29 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Left-Hemisphere Stroke
Interventions: Perfusion functional Magnetic Resonance Imaging (perfusion fMRI); Diagnostic Test
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 100 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Schizophrenia, Schizoaffective Disorder, Control Subjects
Interventions: Positive Emotion Upregulation; Behavioral
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 50 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Prolonged Post-traumatic Stress Disorder
Interventions: Compassion Training; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 25 Years to 65 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Epilepsy
Interventions: fMRI, Neuropsychological Testing, Additional electrode implantation, Electrical brain stimulation; Other
Lead sponsor: Northwell Health; Other
Eligibility: 5 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2029
U.S. locations: 1
States / cities: Great Neck, New York

Conditions: Pulmonary Surgical Procedures
Interventions: 129Xe MRI, 133 Xe scintigraphy; Drug
Lead sponsor: Polarean, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Durham, North Carolina • Cincinnati, Ohio • Charlottesville, Virginia

Conditions: Facial Neuropathy
Interventions: Lamotrigine, Placebo (for Lamotrigine); Drug
Lead sponsor: Pain and Analgesia Imaging and Neuroscience Group; Other
Eligibility: 18 Years to 60 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Glaucoma
Interventions: magnetic resonance imaging (MRI) of the brain; Diagnostic Test
Lead sponsor: Wills Eye; Other
Eligibility: 21 Years and older
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

Markers of Trajectory in Pediatric CRPS

Magnetic Resonance Imaging (MRI) of Neuropsychiatric Patients and Healthy Volunteers

Study of Paroxetine and Fluconazole for the Treatment of HIV Associated Neurocognitive Disorder

Study of Human Sensory Perception

Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

Investigation of Neurofeedback With Real-Time fMRI in Healthy Volunteers and Patients With Hyperkinetic Movement Disorders

Task Atlas: Study to Develop a Task Atlas of Brain Recruitment During a Digital Game-based Program

Theta-Burst Stimulation as a Treatment for Reducing Cocaine Use

Internet-based Conversational Engagement Clinical Trial

Effects of Nicotine and Attention on Frequency Tuning in Auditory Cortex

Neural Substrates of Approach-Avoidance Conflict

Multimodal Investigation of Neural Plasticity

Investigating the Effects of Cannabidiol on Social Anxiety Disorder

Mini Theta Burst TMS in MDD Patients

Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease

Remimazolam NeuroImaging

Sex Differences in Risk for Alcohol Abuse

Brain Markers Predicting Reading Recovery After Stroke

Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Sampling Study

Meditation for Emotional Numbing in Post-Traumatic Stress Disorder

An Examination of Cognitive and Sensorimotor Processes in Patients With Epilepsy

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection

Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI

Does Glaucoma Cause Loss of Brain Function?